March activity for Levetiracetam remained tight as end-market demand and logistical frictions trimmed US supply. Early in the month, Indian API plants held steady, but exporters channelled limited March shipments to faster-paying Asian buyers, narrowing US availability. Mid-month, Trans-Pacific freight costs climbed, and formulary documentation slowed customs clearance, keeping pipeline inventory lean. At the same time, stronger prescribing trends and reimbursement shifts improved patient adherence and sustained wholesaler off-take. The March CFR Los Angeles grade rose sharply from February, signaling a solid demand uptick in the oral API used for antiepileptic therapies. Sector fundamentals remained supportive, aided by stable access to diagnoses for millions of patients and improving adherence through zero-copay tier placements. Distributors held volumes despite cost pressures, while import costs and freight surcharges increased higher landed costs. Looking forward, projections point to additional price gains in April and May, with a modest correction later and gradual recovery into late summer, barring supply shocks.
US Levetiracetam prices moved higher in March as robust end-market demand and logistical frictions tightened effective supply to US buyers. Early March saw operating rates at major Indian API plants remain steady, but exporters diverted limited March batches toward faster-paying Asian buyers, reducing volumes available for US consignments. Moreover, the ongoing US–Israel–Iran conflict has significantly increased production costs in key Asian exporting countries due to elevated energy and logistics expenses. This cost escalation prompted exporters to raise their FOB quotations, which in turn led to higher CFR prices for Levetiracetam during the month. Mid-month freight on the Trans-Pacific Lane climbed, and late-month formulary documentation requirements lengthened customs clearance, keeping pipeline inventory thin. Meanwhile, stronger prescribing trends and reimbursement shifts widened patient adherence and sustained wholesaler off-take, producing a bullish tone that fed through to CFR Los Angeles offers in the latter half of the month.
Pharmaceutical demand...
Leave a Comment
Comments (0)